Description
Recombinant monoclonal antibody to ganglioside GM2. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the CHO cell line L55.
Target
ganglioside GM2
Isotype/Mimetic
IgM
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Methods
Naïve display libraries derived from human B cells, or naïve display libraries from animal B cells or Display libraries from synthetic or natural framework sequences
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-free discovery, Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression